Intravenous Ancrod for the Treatment of Acute Ischemic Stroke Within 6 Hours After Onset of Symptoms
NCT00343174
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
OTHER
Sponsor class
Conditions
Brain Infarction
Cerebral Ischemia
Acute Stroke
Interventions
DRUG:
Ancrod
Sponsor
Heidelberg University